期刊文献+

内皮抑素的低分子肝素修饰及对兔角膜新生血管的抑制作用 被引量:3

Modification of endostatin with low molecular weight heparin and its angiogenesis effects on rabbit corneas
下载PDF
导出
摘要 目的探讨利用低分子肝素对内皮抑素进行结构修饰,并评价其对角膜新生血管(corneal neovas-cularization,CNV)的抑制作用。方法采用化学方法用低分子肝素修饰内皮抑素,碱烧伤法建立兔角膜新生血管模型,分别在球结膜下注射低分子肝素化内皮抑素(Ⅰ组)、内皮抑素(Ⅱ组)和生理盐水(对照组),观察新生血管的生长情况。结果成功的利用低分子肝素对内皮抑素进行了结构修饰,动物实验表明Ⅰ组新生血管的长度、面积、数量、VEGF的表达均明显低于其它两组,差异有统计学意义(P<0.05)。结论低分子肝素化内皮抑素可有效抑制角膜新生血管的生长,效果优于内皮抑素。 Objective To investigate the modification of endostatin (ES) with low molecular weight heparin (LMEH) and its inhibitory effects on corneal neovascularization(CNV). Methods ES was modified with LMWH by a chemical method. The rabbit CNV model was made with alkali burning. LMWH-ES(group 1), ES (group 2) and normal saline(control group) were subconjunctivally injected. Results The blood vessel was shorter and smaller in group 1 than in the other two groups( P 〈 0.05) and the expression of VEGF in group 1 was also significantly lower than that of the other two groups( P 〈 0.05). Conclusions LMWH-ES can effectively inhibit the growth of CNV and is superior to ES.
出处 《山东大学耳鼻喉眼学报》 CAS 2007年第5期471-473,I0001,共4页 Journal of Otolaryngology and Ophthalmology of Shandong University
关键词 低分子肝素 内皮抑素 修饰 角膜 新生血管 Low mglecular weight heparin Endostatin Modification Cornea Neovascularization Rabbit
  • 相关文献

参考文献7

  • 1O'reilly M S,Bcehm T,Folkman J,et al.Endostatin:an endogenous inhibitor of angiognesis and tumor growth[J].Cell,1997,88(2):277-285.
  • 2Robert B M,George K A.Serotonergic facilitation of facial motoneuron excitation[J].Brain Res,1979,169:11-27.
  • 3Feng J,Cai X,Zhao J H,et al.Serotonin receptors modulate CABAA receptor channels through activation of anchored protein kinase C in prefrontal cortical[J].J Neturosci,2001,21(17):6502.
  • 4王晓燕,孙汶生,马春红,张利宁,李欣,曹英林,刘素侠,宋静,韩丽辉.重组人分泌型endostatin的纯化及其抑癌活性探讨[J].中国肿瘤临床,2003,30(2):136-139. 被引量:5
  • 5Kreuger J,Matsumoto T,Vanwildemeersch M,et al.Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function[J].EMBO J,2002,21(23):6303-6311.
  • 6Chang J H,Gabison E E,Kato T,et al.Corneal neovascurization[J].Curr Opin Ophthalmol,2001,12(4):242-249.
  • 7邱培瑾,姚克.角膜新生血管的动物模型[J].国外医学(眼科学分册),2000,24(6):360-363. 被引量:25

二级参考文献6

共引文献28

同被引文献10

  • 1任明华,王淑静,林雪松,徐建永,陶站华,赵炜明,刘兴汉.重组人内皮抑素的结构改造及抗肿瘤活性变化[J].中国生物化学与分子生物学报,2005,21(1):45-52. 被引量:17
  • 2张平,岳滔,朱振宇,郑健粱,林健贤,张文忻,冯官光.内皮抑制素蛋白质的制备及生物学活性测定(英文)[J].国际眼科杂志,2005,5(5):841-846. 被引量:1
  • 3[1]Forkman J.What is the evidence that tumors are angiogenesis dependent[J].J.Natl.cancer.Ins,1995,82:4~6.
  • 4[2]Liekens S,De Clercg E,Neyts J.Angiogenesis,regulators and clinical applications[J].Biochem Pharmacol,2001,61(3):253.
  • 5[3]N oma H,Funatsu H,Yamashita H.Regulation of angiogenesis in diabetic retJnopathy:possible balance between vasacularen dothelial growth f actor andendostatin[J].Arch Ophthalmol,2002,120(8):1075~1080.
  • 6[1]Forkman J.What is the evidence that tumors are angiogenesis dependent[J].J Natl Cancer Ins,1995,82(3):4-6.
  • 7[2]Liekens S,De Clercg E,Neyts J.Angiogenes:regulators and clinical applications[J].Bicchem Pharmacol,2001,61(3):253.
  • 8[3]Noma H,Funatsu H,Yamsshita H.Regulation of angiogenesis in diabetic retinopathy:possible balance between vascularen dothelial growth faetar andendostatin[J].Arch Ophthalmol,2002,120(8):1075-1080.
  • 9李维义,高晓唯,任兵.内皮抑素与眼部新生血管[J].国际眼科杂志,2007,7(5):1393-1395. 被引量:2
  • 10张平,吴德正,岳滔,朱振宇,林建贤,冯官光,郑湖铃.转内皮抑制素基因治疗大鼠角膜新生血管[J].国际眼科杂志,2004,4(1):60-65. 被引量:4

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部